New York S00520 ensures ovarian cancer survivors have the right to access genetic screenings.

New York S00520 amends the public health law to ensure ovarian cancer survivors have the right to access genetic screenings. The bill prohibits denying survivors genetic testing or genomic tumor profiling for inherited and acquired mutations. Screenings must include BRCA1 and BRCA2 gene mutations, Lynch syndrome, and rearrangement analysis of ovarian cancer-related exons. Additional mutations can be tested if medically necessary. The screenings are not subject to frequency caps or other limitations.

New York S00520 ensures ovarian cancer survivors have the right to access genetic screenings.

New York S00520 amends the public health law to ensure ovarian cancer survivors have the right to access genetic screenings. The bill prohibits denying survivors genetic testing or genomic tumor profiling for inherited and acquired mutations. Screenings must include BRCA1 and BRCA2 gene mutations, Lynch syndrome, and rearrangement analysis of ovarian cancer-related exons. Additional mutations can be tested if medically necessary. The screenings are not subject to frequency caps or other limitations.